Skip to main content
. 2019 Sep 4;9:857. doi: 10.3389/fonc.2019.00857

Figure 3.

Figure 3

Knockdown of c-FLIPL enhanced the efficacy of PD-1 blockade in vivo. (A) C57/B6 mice were injected subcutaneously with B16-c-FLIP-shRNA and B16-c-FLIP-control stable cells. After the treatment with PD-1 blockade, tumors were extracted and photographed. (B) Tumor growth curves of C57BL/6 mice. Tumor volumes were calculated at the indicated time points. (C) Tumor weights on the 14th day. Results are mean volume ± sem for 8 mice per group per time point. *P < 0.05 (Student's t-test).